Skip to main content

Advertisement

Table 2 SBRT treatment characteristics

From: Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch® patient registry

  Primary NSCLC Lung Metastases p-value
Number of Lesions 48 66  
Prescribed Dose (Gy)    0.0001
 Median 48 37.5  
 Range (20 – 60) (16 – 60)  
BED10 (Gy)    0.0005
 Median 105.6 93.6  
 Range 48 – 180 37.5 – 180  
Dmax (Gy)    
 Median 72.7 66.2 0.048
 Range (40.5 – 105) (21.7 – 94)  
Number of fractions    0.013
 Median 4 3  
 Range 1–5 1–5